Insiders Destiny Pharma plc

Equities

Delayed London S.E. Other stock markets 07:37:30 2024-04-29 am EDT			5-day change	1st Jan Change
17.57 ^GBX	+8.14%		-23.60%	-74.90%

Apr. 25	Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024
Apr. 25	AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract	AN

Destiny Pharma says former Chair Nigel Rudd return to role	23-07-25	AN
Former Destiny Pharma Chairman Reprises Role	23-07-25	MT
Destiny Pharma plc Appoints Sir Nigel Rudd as New Chairman	23-07-25	CI
Destiny Pharma Welcomes New CEO; Chair Steps Down	23-07-19	MT
Destiny Pharma appoints Chris Tovey as CEO; Chair resigns	23-07-19	AN
Destiny Pharma plc Announces Departure of Nick Rodgers as Chairman	23-07-19	CI
Destiny Pharma plc Announces CEO Changes	23-07-19	CI
Ecofin US Renewables expects to pay reduced dividend	23-06-29	AN
Destiny Pharma picks interim CEO as Clark makes quick exit	23-05-25	AN
Destiny Pharma Shares Drop 11% Amid CEO Departure	23-05-25	MT
Destiny Pharma plc Announces CEO Changes	23-05-25	CI
Destiny Pharma plc Announces the Step Down of Neil Clark from Board	23-05-25	CI
Destiny Pharma plc Announces Board Changes	22-05-26	CI
Destiny Pharma Names New CFO	22-05-03	MT
Destiny Pharma plc Appoints Yuri Martina as Chief Medical Officer	22-05-03	CI
Destiny Pharma plc Announces Peter Morgan, Non-Executive Director, Has Decided to Step Down from the Board with Effect from 31 March 2022	21-11-15	CI
Destiny Pharma plc Announces the Appointment of Mark Wilcox to its Scientific Advisory Board	21-02-02	CI
Destiny Pharma Appoints Stephanie Bewick as CBO	21-01-06	CI
Destiny Pharma Appoints Dale Gerding to its Scientific Advisory Board	20-12-22	CI
Destiny Pharma plc Appoints Debra Barker as an Independent Non-Executive Director with Effect from 1 January 2020	19-12-02	CI

No results for this search